Abstract
Spinal cord stimulation (SCS) has been shown to effectively relieve chronic intractable pain. However, in a portion of patients,1 the therapeutic benefits of SCS wane over time. Stimulation of the dorsal root ganglion (DRG) can provide more effective treatment to patients with complex regional pain syndrome and peripheral causalgia than SCS due in part to more focused relief of their painful areas.2 PROLONG (NCT039088476) is a multi-center, open-label, post-market study that prospectively observes subjects who switch to burst capable devices or DRG stimulation after loss of pain relief with their previous SCS system. Herein we report 12-month results of subjects who received DRG stimulation for their waning SCS therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
